Our results indicated most DNA methylation regulators (DNMT1, MBD3, UHRF1, and TDG) with amplificated CNV demonstrated markedly higher expression in GBM, which revealed that the alterations of CNV could be an important element resulting in perturbations on the DNA methylation regulators expression in glioma. Here, UHRF1 is linked to central nervous system cancer.